H. Heuzeroth

Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease

C. Ruppert, S. Ciesek, A. Zeiher, 2021, PloS one.

Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities

C. Bode, M. Lablans, K. Kaier, 2021, Clinical Research in Cardiology.

Development and validation of a simplified risk score for the prediction of critical COVID‐19 illness in newly diagnosed patients

C. Spinner, U. Heemann, J. Vehreschild, 2021, medRxiv.

The 4-Aminopyridine Model of Acute Seizures in vitro Elucidates Efficacy of New Antiepileptic Drugs

M. Holtkamp, P. Fidzinski, Matthias Wawra, 2019, Front. Neurosci..